Analyst Roy Buchanan works at JMP and is focused on the Healthcare sector with 38 price targets and ratings documented since 2020 spanning on 4 stocks. Analyst's average stock valuation to be materialised ratio is 30.3% with an average time for price targets to be met of 82.75 days.
Most recent stock forecast was given on CVAC, CureVac N.V. at 17-Nov-2022.
Roy Buchanan best performing recommendations are on ENTA (ENANTA PHARMACEUTICALS, INC).
The best stock recommendation documented was for ENTA (ENANTA PHARMACEUTICALS, INC) at 10/4/2021. The price target of $73 was fulfilled within 18 days with a profit of $12.81 (21.28%) receiving and performance score of 11.82.
Average potential price target upside